Skip to main content

Table 2 Univariate and multivariate Cox proportional hazard regression analyses of recurrence-free survival

From: Are urothelial carcinomas of the upper urinary tract a distinct entity from urothelial carcinomas of the urinary bladder? Behavior of urothelial carcinoma after radical surgery with respect to anatomical location: a case control study

 

Univariate

Multivariate

 

HR (95% CI)

P value

HR (95% CI)

P value

Tumor location

    

Upper urinary tract vs. Bladder

0.906 (0.658-1.248)

0.546

  

Age, years

1.016 (0.999-1.033)

0.057

  

Sex

    

Female vs. Male

1.098 (0.719-1.676)

0.665

  

Body mass index, kg/m2

0.947 (0.898-0.999)

0.049

0.980 (0.929-1.033)

0.453

ASA score

    

≥2 vs.1

0.927 (0.670-1.282)

0.645

  

Hydronephrosis

    

Present vs. Absent

1.609 (1.165-2.221)

0.004

1.378 (0.984-1.928)

0.062

Pathological T category

    

pT2 vs. ≤pT1

3.588 (1.992-6.461)

<0.001

2.875 (1.573-5.256)

0.001

≥pT3 vs. ≤pT1

6.748 (4.087-11.141)

<0.001

4.675 (2.736-7.990)

<0.001

Pathological N category

    

pNx vs. pN-

1.174 (0.810-1.700)

0.397

1.202 (0.805-1.794)

0.369

pN+ vs. pN-

3.232 (2.113-4.942)

<0.001

1.847 (1.180-2.889)

0.007

Tumor grade

    

III vs. ≤II

1.955 (1.416-2.699)

<0.001

1.151 (0.802-1.652)

0.447

LVI

    

Present vs. Absent

2.639 (1.911-3.645)

<0.001

1.496 (1.042-2.149)

0.029

Associated CIS

    

Present vs. Absent

1.054 (0.681-1.631)

0.815

  

Surgical margin

    

Positive vs. Negative

2.777 (1.675-4.605)

<0.001

1.349 (0.797-2.282)

0.265

  1. Abbreviations: HR = hazard ratio, CI = confidence interval, ASA = American Society of Anesthesiologists, LVI = Lymphovascular invasion, CIS = carcinoma in situ.